Skip to main content
Log in

Adult-onset glutaric aciduria type I: rare presentation of a treatable disorder

  • Original Article
  • Published:
neurogenetics Aims and scope Submit manuscript

Abstract

Glutaric aciduria type I (GA1; OMIM #231670) is an autosomal recessively inherited and treatable disorder characterized by the accumulation and irregular excretion of glutaric acid due to a defect in the glutaryl-CoA dehydrogenase enzyme involved in the catabolic pathways of l-lysine, l-hydroxylysine, and l-tryptophan. Glutaryl-CoA dehydrogenase is encoded by the GCDH gene (OMIM #608801), and several mutations in this gene are known to result in GA1. GA1 usually presents in the first 18–36 months of life with mild or severe acute encephalopathy, movement disorders, and striatal degeneration. Few cases of adult-onset GA1 have been described so far in the literature, often with non-specific and sometimes longstanding neurological symptoms. Since a preventive metabolic treatment is available, neurologists must be aware of this rare but likely underdiagnosed presentation, especially when typical neuroimaging features are identified. Here, we describe 35-year-old presenting with headache and subjective memory problems. There was no history of dystonic movement disorders. Neurological examination and neurocognitive tests were normal. Brain MRI scan revealed white matter abnormalities associated with subependymal nodules and mild frontotemporal hypoplasia suggestive of glutaric aciduria type 1 (GA1). Genetic testing confirmed the presence of homozygous c.1204C > T (p.R402W) variant in the GCDH gene, inherited from heterozygous parents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Lindner M, Kölker S, Schulze A, Christensen E, Greenberg CR, Hoffmann GF (2004) Neonatal screening for glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis 27(6):851–859

    Article  CAS  Google Scholar 

  2. Kölker S, Christensen E, Leonard JV, Greenberg CR, Boneh A, Burlina AB, Burlina AP, Dixon M, Duran M, García Cazorla A, Goodman SI, Koeller DM, Kyllerman M, Mühlhausen C, Müller E, Okun JG, Wilcken B, Hoffmann GF, Burgard P (2011) Diagnosis and management of glutaric aciduria type I – revised recommendations. J Inherit Metab Dis 34(3):677–694

    Article  Google Scholar 

  3. Zschocke J, Quak E, Guldberg P, Hoffmann GF (2000) Mutation analysis in glutaric aciduria type I. J Med Genet 37(3):177–181

    Article  CAS  Google Scholar 

  4. Sauer SW, Okun JG, Fricker G, Mahringer A, Müller I, Crnic LR, Mühlhausen C, Hoffmann GF, Hörster F, Goodman SI, Harding CO, Koeller DM, Kölker S (2006) Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids secondary to limited flux across the blood-brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl-CoA dehydrogenase deficiency. J Neurochem 97(3):899–910

    Article  CAS  Google Scholar 

  5. Funk CB, Prasad AN, Frosk P, Sauer S, Kölker S, Greenberg CR, del Bigio M (2005) Neuropathological, biochemical and molecular findings in a glutaric acidemia type 1 cohort. Brain 128(Pt 4):711–722

    Article  Google Scholar 

  6. Baric I et al (1998) Diagnosis and management of glutaric aciduria type I. J Inherit Metab Dis 21(4):326–340

    Article  CAS  Google Scholar 

  7. Tuncel AT et al (2018) Organic acidurias in adults: late complications and management. J Inherit Metab Dis 41(5):765–776.a

    Article  CAS  Google Scholar 

  8. Heringer J, Boy SP, Ensenauer R, Assmann B, Zschocke J, Harting I, Lücke T, Maier EM, Mühlhausen C, Haege G, Hoffmann GF, Burgard P, Kölker S (2010) Use of guidelines improves the neurological outcome in glutaric aciduria type I. Ann Neurol 68(5):743–752

    Article  Google Scholar 

  9. Fu Z, Wang M, Paschke R, Rao KS, Frerman FE, Kim JJ (2004) Crystal structures of human glutaryl-CoA dehydrogenase with and without an alternate substrate: structural bases of dehydrogenation and decarboxylation reactions. Biochemistry 43(30):9674–9684

    Article  CAS  Google Scholar 

  10. Berman HM et al (2000) The Protein Data Bank. Nucleic Acids Res 28(1):235–242

    Article  CAS  Google Scholar 

  11. Krieger E et al (2009) Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: four approaches that performed well in CASP8. Proteins 77(Suppl 9):114–122

    Article  CAS  Google Scholar 

  12. Tina KG, Bhadra R, Srinivasan N (2007) PIC: Protein Interactions Calculator. Nucleic Acids Res 35(Web Server issue):W473–W476

    Article  CAS  Google Scholar 

  13. Choi Y, Chan AP (2015) PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics 31(16):2745–2747

    Article  CAS  Google Scholar 

  14. Sim NL et al (2012) SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res 40(Web Server issue):W452–W457

    Article  CAS  Google Scholar 

  15. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR (2010) A method and server for predicting damaging missense mutations. Nat Methods 7(4):248–249

    Article  CAS  Google Scholar 

  16. Goodman SI and Frerman F.. (2001) Organic acidemias due to defects in lysine oxidation: 2-ketoadipic acidemia and glutaric acidemia. McGraw-Hill Inc.: New York, USA. p. 2195–2204

  17. Kulkens S et al (2005) Late-onset neurologic disease in glutaryl-CoA dehydrogenase deficiency. Neurology 64(12):2142–2144

    Article  CAS  Google Scholar 

  18. Bahr O et al (2002) Adult onset glutaric aciduria type I presenting with a leukoencephalopathy. Neurology 59(11):1802–1804

    Article  CAS  Google Scholar 

  19. Fraidakis MJ, Liadinioti C, Stefanis L, Dinopoulos A, Pons R, Papathanassiou M, Garcia-Villoria J, Ribes A (2015) Rare late-onset presentation of glutaric aciduria type I in a 16-year-old woman with a novel GCDH mutation. JIMD Rep 18:85–92

    Article  CAS  Google Scholar 

  20. Badve MS, Bhuta S, McGill J (2015) Rare presentation of a treatable disorder: glutaric aciduria type 1. N Z Med J 128(1409):61–64

    PubMed  Google Scholar 

  21. Boy N, Mengler K, Thimm E, Schiergens KA, Marquardt T, Weinhold N, Marquardt I, Das AM, Freisinger P, Grünert SC, Vossbeck J, Steinfeld R, Baumgartner MR, Beblo S, Dieckmann A, Näke A, Lindner M, Heringer J, Hoffmann GF, Mühlhausen C, Maier EM, Ensenauer R, Garbade SF, Kölker S (2018) Newborn screening: a disease-changing intervention for glutaric aciduria type 1. Ann Neurol 83(5):970–979

    Article  CAS  Google Scholar 

  22. Wang Q, Li X, Ding Y, Liu Y, Song J, Yang Y (2014) Clinical and mutational spectra of 23 Chinese patients with glutaric aciduria type 1. Brain Dev 36(9):813–822

    Article  CAS  Google Scholar 

  23. Boy N et al (2017) Extrastriatal changes in patients with late-onset glutaric aciduria type I highlight the risk of long-term neurotoxicity. Orphanet J Rare Dis 12

  24. Herskovitz M, Goldsher D, Sela BA, Mandel H (2013) Subependymal mass lesions and peripheral polyneuropathy in adult-onset glutaric aciduria type I. Neurology 81(9):849–850

    Article  Google Scholar 

  25. Kolker S et al (2015) The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype. J Inherit Metab Dis 38(6):1059–1074

    Article  Google Scholar 

  26. Korman SH, Jakobs C, Darmin PS, Gutman A, van der Knaap M, Ben-Neriah Z, Dweikat I, Wexler ID, Salomons GS (2007) Glutaric aciduria type 1: clinical, biochemical and molecular findings in patients from Israel. Eur J Paediatr Neurol 11(2):81–89

    Article  Google Scholar 

  27. Baric I, Wagner L, Feyh P, Liesert M, Buckel W, Hoffmann GF (1999) Sensitivity and specificity of free and total glutaric acid and 3-hydroxyglutaric acid measurements by stable-isotope dilution assays for the diagnosis of glutaric aciduria type I. J Inherit Metab Dis 22(8):867–881

    Article  CAS  Google Scholar 

  28. Christensen E, Ribes A, Merinero B, Zschocke J (2004) Correlation of genotype and phenotype in glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis 27(6):861–868

    Article  CAS  Google Scholar 

  29. Kolker S et al (2006) Natural history, outcome, and treatment efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency. Pediatr Res 59(6):840–847

    Article  Google Scholar 

  30. Hedlund, G.L., N. Longo, and M. Pasquali, Glutaric acidemia type 1. Am J Med Genet C Semin Med Genet, 2006. 142c(2): p. 86–94

  31. Heringer J et al (2015) Newborn screening for glutaric aciduria type I: benefits and limitations. Int J Neonatal Screen 1(2):57–68

    Article  Google Scholar 

  32. Westover JB, Goodman SI, Frerman FE (2003) Pathogenic mutations in the carboxyl-terminal domain of glutaryl-CoA dehydrogenase: effects on catalytic activity and the stability of the tetramer. Mol Genet Metab 79(4):245–256

    Article  CAS  Google Scholar 

  33. Keyser B, Mühlhausen C, Dickmanns A, Christensen E, Muschol N, Ullrich K, Braulke T (2008) Disease-causing missense mutations affect enzymatic activity, stability and oligomerization of glutaryl-CoA dehydrogenase (GCDH). Hum Mol Genet 17(24):3854–3863

    Article  CAS  Google Scholar 

  34. Kolker S et al (2007) Guideline for the diagnosis and management of glutaryl-CoA dehydrogenase deficiency (glutaric aciduria type I). J Inherit Metab Dis 30(1):5–22

    Article  CAS  Google Scholar 

  35. Bijarnia S, Wiley V, Carpenter K, Christodoulou J, Ellaway CJ, Wilcken B (2008) Glutaric aciduria type I: outcome following detection by newborn screening. J Inherit Metab Dis 31(4):503–507

    Article  CAS  Google Scholar 

  36. Boneh A, Beauchamp M, Humphrey M, Watkins J, Peters H, Yaplito-Lee J (2008) Newborn screening for glutaric aciduria type I in Victoria: treatment and outcome. Mol Genet Metab 94(3):287–291

    Article  CAS  Google Scholar 

  37. Kolker S et al (2015) The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation. J Inherit Metab Dis 38(6):1041–1057

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pınar Gelener.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gelener, P., Severino, M., Diker, S. et al. Adult-onset glutaric aciduria type I: rare presentation of a treatable disorder. Neurogenetics 21, 179–186 (2020). https://doi.org/10.1007/s10048-020-00610-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10048-020-00610-9

Keywords

Navigation